Phytochem Remedies (India) Ltd IPO Subscription Status: IPO Subscribed 0.57 Times on Final Day

Mumbai, 22 December 2025: Corrugated boxes and boards manufacturer Phytochem Remedies (India) Ltd ₹38.22 crores IPO was subscribed 0.57 times on it final day. The IPO, which opened for subscription status on December 18, 2025 and closed today, December 22, 2025.  

The allotment for the Phytochem Remedies IPO is expected to be finalised on December 23, 2025. Phytochem Remedies IPO will list on BSE SME with a tentative listing date fixed as December 26, 2025. The IPO is entirely a fresh issue of 39 lakh equity shares at a price of ₹98 per scrip worth ₹38.22 crore. 

Incorporated in 2002, Phytochem Remedies is a manufacturer of corrugated boxes and corrugated board solutions, catering primarily to industries such as food & beverages, FMCG, pesticides, pharmaceuticals, and automotive. The company operates from its strategically located manufacturing units in Bari Brahmana, Jammu. Its products include corrugated boxes (3-ply, 5-ply, and 7-ply), printed corrugated boxes, corrugated rolls, and corrugated pads and sheets. 

Phytochem Remedies IPO Subscription Status at 0.57 Times on Final Day 

Phytochem Remedies’ initial public offering IPO was subscribed 0.57 times by the end of Day -3 on 22nd December, 2025. The issue received modest response from retail investors, with the Individual Investors portion subscribed 0.83 times and Non-Institutional Buyers (NII) subscribed 0.31 times. The QIB (qualified institutional buyers) portion (other than the anchor investors portion) was unsubscribed. The market maker portion was fully subscribed at 1 time. In all, against 37.03 lakh shares on offer, bids were received for 21.10 lakh shares, translating to sum of ₹20.69 crores at the upper price band. 

Phytochem Remedies IPO Structure and Key Details 

Phytochem Remedies IPO is a fixed price issue of ₹38.22 crores. The issue is entirely a fresh issue of 0.39 crore shares of ₹38.22 crore. The IPO price is ₹98.00 per share. The lot size for an application is 1,200. The minimum amount of investment required by an individual investor (retail) is ₹2,35,200.00 (2,400 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (3,600 shares), amounting to ₹3,52,800. 

Mefcom Capital Markets Ltd. is the book running lead manager and Bigshare Services Pvt. Ltd. is the registrar of the issue. The Market Maker of the company is Aftertrade Broking Pvt. Ltd. 

Phytochem Remedies Proceeds to be Used towards Capital Expenditure and Debt Repayment 

The net proceeds from the fresh issue will be used to fund capital expenditure requirements for the purchase of equipment/machineries and towards civil construction (₹19.48crore), repayment/pre-payment, in full or in part, of certain borrowings availed by the company (₹9.37 crore), and for general corporate purposes (₹5.64 crore) 

Phytochem Remedies Financial Performance Up 12% in Revenues and PAT Surges 94% 

Phytochem Remedies showed robust financials growth from FY24 to FY25 with a 12% growth in revenues and a staggering 94% growth in profit after taxes. Its gross income rose from ₹32.90 crore in FY24 to ₹36.81 crore in FY25 and its asset rose from ₹41.85 crore in FY24 to ₹44.50 crore in FY25, while that of September 2025 touched ₹53.68 crore. EBITDA witnessed strong uptick to ₹8.69 crore in FY25 compared to FY24 which stood at ₹5.88 crore.  

Source https://www.phytochem.co.in/wp-content/uploads/2025/06/Draft-Prospectus-Final.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.  

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.  

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations